Guilherme Dias de Melo is veterinarian. He obtained his degree in Veterinary Medicine (december 2010), his MD in Veterinary Sciences (june 2012) and his PhD in Veterinary Sciences (june 2015) at the Sao Paulo State University – Araçatuba, Brazil. He is currently a Researcher at the Lyssavirus Epidemiology and Neuropathology Unit.
About
Courses
Rabies MOOC
This course explains the pathophysiology, epidemiology, vaccines and elimination strategies of the rabies virus. >>Register here << Rabies is a fatal encephalitis caused by a Lyssavirus primarily transmitted by the bite or scratch of […]
Projects
CV
Education
Year | Degree | Field | Institution |
2012-2015 | PhD | Veterinary Science | Sao Paulo State University, Araçatuba-SP, Brazil |
2011-2012 | MSc | Veterinary Science | Sao Paulo State University, Araçatuba-SP, Brazil |
2006-2010 | DVM | Veterinary Medicine | Sao Paulo State University, Araçatuba-SP, Brazil |
Training
Year | Field | Institution |
2014-2015 | Immunology/Parasitology | Trypanosomatids Infectious Processes, Institut Pasteur, Paris, France |
2011-2011 | Veterinary Pathology | Institut of Veterinary Pathology, Justus-Liebig University, Giessen, Germany |
Postdoctoral Training
- 2018-2022 – Lyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, Paris, France
- 2015-2017 – Trypanosomatids Infectious Processes, Institut Pasteur, Paris, France
Awards and Grants
- 2022 – International Prize in Planetary Health. Université Franco-Allemande – Lyon, France
- 2006-2015 – Fellow of Sao Paulo Research Foundation (FAPESP, Fundação de Amparo à Pesquisa do Estado de São Paulo) (DVM #2006/56724-3; MSc #2010/12473-2; PhD #2012/10415-0)
- 2013 – ICI-AAI Travel Grant for Immunologists from Developing Countries – 15th International Congress of Immunology (ICI) – Milan, Italy
- 2013 – Best poster in Cellular and Molecular Biology – Fifth World Congress on Leishmaniasis (World Leish 5) – Porto de Galinhas, Brazil
- 2011 – Travel Grant – 11th European School of Neuroimmunology (ESNI), Glasgow, Scotland
Publications
Download-
2022Susceptibilities of CNS Cells towards Rabies Virus Infection Is Linked to Cellular Innate Immune Responses., Viruses 2022 Dec; 15(1): .
-
2022Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2., J Exp Med 2022 Jul; 219(7): .
-
2021A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters., Nat Commun 2021 11; 12(1): 6277.
-
2021Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin., EMBO Mol Med 2021 08; 13(8): e14122.
-
2021COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters., Sci Transl Med 2021 06; 13(596): .
-
2020A combination of two human monoclonal antibodies cures symptomatic rabies., EMBO Mol Med 2020 Sep; (): e12628.
-
2020Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein., Nat Commun 2020 01; 11(1): 596.
-
2015Feasibility and safety of intrathecal transplantation of autologous bone marrow mesenchymal stem cells in horses, BMC Vet. Res. 2015;11:63.
-
2014Compartmentalized gene expression of toll-like receptors 2, 4 and 9 in the brain and peripheral lymphoid organs during canine visceral leishmaniasis, Parasite Immunol. 2014 Dec;36(12):726-31.
-
2014First detection of Leishmania infantum DNA within the brain of naturally infected dogs, Vet. Parasitol. 2014 Aug;204(3-4):376-80.
-
+View full list of publications